SOX2 and glioblastoma: A growing body of evidence indicates that CD133, CD44, and Sox2 were involved in sustaining GSCs self-renewal, which facilitates GBM tumorigenesis (Bao et al., 2006; Yin et al., 2007; Wei et al., 2013; Zhu et al., 2020).